Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. - Wikidata - awgldk - TriplyDB

Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

http://www.wikidata.org/entity/Q33818370

about

The Role of Neuropeptides in Mouse Models of Colitis Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer Protective and pro-inflammatory roles of intestinal bacteria Modelling of mouse experimental colitis by global property screens: a holistic approach to assess drug effects in inflammatory bowel disease Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation.Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease.Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.Targeting T-cell migration in inflammatory bowel disease.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Rodent intestinal epithelial carcinogenesis: pathology and preclinical models.Mechanisms of initiation and progression of intestinal fibrosis in IBD.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.Possible Involvement of Liver Resident Macrophages (Kupffer Cells) in the Pathogenesis of Both Intrahepatic and Extrahepatic Inflammation Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis.Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: effect of genetic background.Humanizing the mouse immune system to study splanchnic organ inflammation.Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium.The Bisphosphonate Pamidronate is an Intestinal Antiinflammatory Agent in Rat and Mouse Experimental Colitis.Sinomenine alleviates dextran sulfate sodium‑induced colitis via the Nrf2/NQO‑1 signaling pathway

P2860

Q26773507-91457EB1-BD13-49EE-9B15-DB7355818201 Q27306938-75891334-36CD-49CD-9C2F-12BCC5955E66 Q28273923-80976E01-D067-45EA-80B0-AE952E617B67 Q28478953-0C5302E3-4B41-42B6-8725-00ACD5E97006 Q35686196-5A24E01C-C00F-4606-A977-BCAA04CAD200 Q35738486-E3A44C13-7D5E-47DF-9462-3AF099300233 Q37265675-74A20F1B-B106-4A1F-BE9C-3E5EAA71CE60 Q37539275-63AB4D5B-38E4-4D1E-A3DE-A2E1942F5172 Q38033380-9A6FE4A4-D6B2-408C-92AE-5CE729AC6722 Q38040430-FB2FC67F-D957-4CEA-82C3-26C17F3A2881 Q38132555-89E6B958-AF45-421C-8455-2B5CF4944CBF Q38157711-5B3D5D85-5B31-4261-967F-D179F14B4ED0 Q38293779-9039BC34-063F-496F-A264-AE21BC629659 Q38460376-23E138F7-905B-4E24-AB09-A6C803C91597 Q39006025-D2343292-9EAC-4C42-9925-73A7F4BE195A Q41208723-0E153396-26AA-4AC1-9568-17D5031806D5 Q42177653-13B902B3-B037-4DA5-9647-0B04DC9214E0 Q42448875-4F8C836C-7F6D-4740-9C87-F4A09D78BD3B Q51039914-88D50316-8039-461B-9307-78BACAA27B3C Q52634041-981614A5-BF44-4837-9F41-53B951EE1869 Q53625447-56E29911-FBBD-4524-A65A-460D6746AB35 Q54765665-FE545364-59D3-4331-876E-B0BD33A2E4A5 Q58789168-ABF678BC-693F-48E8-9FE8-A5BE93B976C0

P2860

Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

http://www.wikidata.org/entity/Q33818370

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacological intervention s ...... data into new drug therapies.

@ast

Pharmacological intervention s ...... data into new drug therapies.

@en

type

label

Pharmacological intervention s ...... data into new drug therapies.

@ast

Pharmacological intervention s ...... data into new drug therapies.

@en

prefLabel

Pharmacological intervention s ...... data into new drug therapies.

@ast

Pharmacological intervention s ...... data into new drug therapies.

@en

P1433

Q33818370-B2E4B5C8-6B33-4CE1-8433-7B1BA52249C4

P1476

Q33818370-FD7CC42E-5E16-4824-8E62-13E0D8E44B8F

P2093

Q33818370-33DE5AE5-2F14-4697-8D05-4A4768254AC0

Q33818370-AA17920B-F3CB-4E6F-8B92-62A29F71BD96

Q33818370-D238D631-E104-4160-A741-A4AC1508940C

Q33818370-E324FEA2-2F75-465D-B274-AEE28CA86E9D

P2860

Q33818370-0164400B-74AC-4421-B3A6-100DE3AFFB4A

Q33818370-03BCEB32-7A6E-4F61-8F8C-FF4264047D44

Q33818370-04B41B58-2213-44F5-99E0-EC8690D45464

Q33818370-07CCCF79-737D-4B0E-980B-24E0D83040A9

Q33818370-0872C0ED-47EF-45CA-9A5D-556B06FDF293

Q33818370-09835D9E-5FC8-4159-B579-71B3EA9B0C2A

Q33818370-0AF6C8DD-E68E-488E-8DB7-F19BC314BFDF

Q33818370-0B60D1AD-35A5-4C21-A149-95353B448E2E

Q33818370-1077AFAA-030C-4BCD-826C-E6BE2F878F5E

Q33818370-11DCBB93-A1D0-4F8B-8DB6-3660514E6B6D

P304

Q33818370-AD5CF8F2-EB3C-497F-8309-EFCF5E9D163A

P31

Q33818370-C9E1E858-1302-486C-B50F-C22ABAB42955

P356

Q33818370-AA800E44-B258-4BC4-8466-AB33C5C6DC81

P433

Q33818370-D56BD7FE-50C7-460E-AB77-F17254E18A3B

P478

Q33818370-C8B8D73A-55D3-4B14-A7CF-FA99BB3DC5A8

P577

Q33818370-86E44667-8D3D-42A2-86B6-CE540C6891F2

P5875

Q33818370-05AAED59-AC45-4DBA-8637-A93C5B202A0B

P698

Q33818370-49CBFED2-699F-4C9E-8B67-06D8CC074E37

P921

Q33818370-89D77D02-DCD1-4DC2-9FD0-6946560D224B

P932

Q33818370-8B41EC09-AA74-4935-85BD-0E6F50934D76

P356

P1433

Inflammatory Bowel Diseases

P1476

Pharmacological intervention s ...... data into new drug therapies.

@en

P2093

Fridrik Karlsson

http://www.w3.org/2001/XMLSchema#string

Iurii Koboziev

http://www.w3.org/2001/XMLSchema#string

Matthew B Grisham

http://www.w3.org/2001/XMLSchema#string

Songlin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Can animal models of disease reliably inform human studies?

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

Unravelling the pathogenesis of inflammatory bowel disease

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

P304

1229-1245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.21557

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49827802

http://www.w3.org/2001/XMLSchema#string

P698

21312318

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3075372

http://www.w3.org/2001/XMLSchema#string